Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Rhythm Biosciences Ltd. ( (AU:RHY) ) has provided an update.
Rhythm Biosciences Ltd has applied for quotation on the ASX of 235,134 additional ordinary fully paid shares, designated under the code RHY. The new securities arise from the exercise or conversion of existing options or other convertible instruments, modestly expanding the company’s quoted share capital and potentially enhancing liquidity for shareholders while reflecting ongoing alignment between capital structure and corporate development needs.
The most recent analyst rating on (AU:RHY) stock is a Hold with a A$0.20 price target. To see the full list of analyst forecasts on Rhythm Biosciences Ltd. stock, see the AU:RHY Stock Forecast page.
More about Rhythm Biosciences Ltd.
Rhythm Biosciences Ltd is an Australian-listed biotechnology company focused on developing diagnostic solutions in the healthcare sector. Its ordinary fully paid shares trade on the ASX under the ticker RHY, providing investors exposure to innovation in medical diagnostics and related technologies.
Average Trading Volume: 955,988
Technical Sentiment Signal: Buy
Current Market Cap: A$76.09M
For a thorough assessment of RHY stock, go to TipRanks’ Stock Analysis page.